Overview

SUBLOCADE Rapid Initiation Study

Status:
Completed

Trial end date:
2019-12-26

Target enrollment:

Participant gender:

Summary

This study is to evaluate the safety and tolerability of initiating SUBLOCADE™ treatment following a shorter period of transmucosal (TM) buprenorphine treatment.

Phase:

Phase 4

Details

Lead Sponsor:

Indivior Inc.

Treatments:

Buprenorphine